Clinical outcomes associated with kidney function changes in anticoagulated atrial fibrillation patients: An ancillary analysis from the BOREALIS trial

BACKGROUND: Patients with atrial fibrillation (AF) and chronic kidney disease represent a high‐risk group for thromboembolism and bleeding. AIMS: To explore the relationship between kidney function changes and outcomes of stroke/systemic embolism (SE), major bleeding and all‐cause death in anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Ying, Shantsila, Alena, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132193/
https://www.ncbi.nlm.nih.gov/pubmed/32256875
http://dx.doi.org/10.1002/joa3.12306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132193/
https://www.ncbi.nlm.nih.gov/pubmed/32256875
http://dx.doi.org/10.1002/joa3.12306

Ejemplares similares